Acelpa Health

What Acelpa Health does

Acelpa Health is a national specialty infusion platform that consolidates five affiliated specialty infusion providers (California Specialty Pharmacy, ContinuumRx, Hawaii Specialty Pharmacy, Continuum Health, and Integrated Care Systems) under a single integrated care model headquartered in Whittier, California. The company delivers specialty infusion therapies for patients with complex, chronic, acute, and rare conditions through three channels: 15 ambulatory infusion centers (AICs), home infusion delivery with nursing coordination, and provider office administration. It operates 9 accredited specialty pharmacies with access to 100+ limited distribution drugs across 32 states plus DC, Guam, and the U.S. Virgin Islands, and holds URAC and ACHC accreditations, HIPAA-compliant operations, and cGMP/USP compliance.

The underlying technology stack includes cloud-based pharmacy management systems enabling remote order entry and fulfillment, a proprietary patient portal providing real-time visibility into prescription status and therapy progress, secure messaging for cross-location collaboration, and continuous wireless temperature monitoring with predictive analytics for cold-chain integrity. A specialized Immunoglobulin (Ig) Center of Excellence, staffed by Ig Certified Pharmacists (IgCP) and Ig Certified Nurses (IgCN), provides dedicated IVIG and SCIg support.

Acelpa Health generates revenue primarily through dispensing fees, medication margins, and facility/administration fees across its pharmacy and AIC network, with additional managed-services revenue from home infusion logistics and emerging value-based contract arrangements with payors and risk-bearing entities. Go-to-market is enterprise-field-sales oriented, targeting four customer segments — patients, payors and managed care organizations, healthcare providers, and pharmaceutical manufacturers — with a content-driven marketing approach (LinkedIn, blog/educational content, PRNewswire distribution) and reported performance metrics of 98%+ adherence and 33-53% lower cost versus hospital outpatient infusion. The company is led by President and CEO George Kridner and was formed in June 2025 as a privately held LLC.

Name

Acelpa Health

Legal name

Acelpa Health, LLC

Website

https://acelpahealth.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

101–250 employees

Short description

Acelpa Health is a national specialty infusion platform uniting five affiliated specialty pharmacies and 15 ambulatory infusion centers across 32 states to deliver high-cost infusion therapies for patients with complex, chronic, acute, and rare conditions, serving payors, providers, and pharmaceutical manufacturers.

Ownership category

akta.pro rank

Product category

Specialty Infusion Pharmacy Services

NAICS

Home Health Care Services (621610)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

Keywords

• Specialty infusion services
• Home infusion therapy
• Ambulatory infusion centers
• Specialty pharmacy services
• Immunoglobulin therapy

Headquarters

HQ city

Whittier

HQ country

United States

HQ region

North America

Offices19 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Services: Specialty infusion pharmacy services providing medications for complex, chronic, acute, and rare conditions. Revenue generated through dispensing fees, coordination services, and medication margins across nine accredited specialty pharmacies.
2. Ambulatory Infusion Center Services: Delivery of infusion therapies at 15 ambulatory infusion centers across the network, generating facility and administration fees.
3. Home Infusion Delivery: Home delivery of specialty medications and infusion therapies, coordinating nursing support and medication logistics directly to patients.
4. Payor Partnership Programs: Outcome-based programs designed with payors and risk-bearing entities to improve care quality and enhance cost efficiency, potentially including value-based contract arrangements.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Acelpa Health is a national specialty infusion platform that connects specialty infusion pharmacies and providers to deliver coordinated therapies for patients with complex, chronic, acute, and rare conditions. It operates nine accredited specialty pharmacies and 15 ambulatory infusion centers, offering home infusion delivery, provider office administration, and clinical care coordination across 32 states plus DC, Guam, and the U.S. Virgin Islands.

Product overview

Acelpa Health is a national platform that unities specialty infusion providers under one umbrella, combining national reach with local expertise. The platform comprises five affiliated specialty pharmacies (California Specialty Pharmacy, ContinuumRx, Hawaii Specialty Pharmacy, Continuum Health, and Integrated Care Systems), offering services across 28 locations (including 15 ambulatory infusion centers) in 32 states plus DC, Guam, and US Virgin Islands. The core offering is specialty infusion services delivered through two channels: ambulatory infusion centers (AIC) and home infusion. A specialized Immunoglobulin (Ig) Center of Excellence provides focused IVIG and SCIg therapy support.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Infusion Services
• Immunoglobulin (Ig) Center of Excellence

Quantifiable outcome

• 98%+ adherence rates at California Specialty Pharmacy, reducing therapy gaps, avoidable hospitalizations, and emergency interventions
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Immunoglobulin National Society (IGNS)coreStrategic or Co-development PartnerAcelpa Health maintains affiliation with the Immunoglobulin National Society, which advances IG therapy practice. The IGNS logo appears on the company website footer indicating membership or alignment with the organization's standards and practices for immunoglobulin therapy.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PromptCare: Specialty home infusion and respiratory services company serving pediatric and adult patients with complex conditions. Comparable in home and alternate-site infusion services with national coverage.
• Nufactor: Specialty pharmacy and home infusion provider focused on immune disorders, neurology, and rare conditions. Comparable specialty infusion platform with strong IG and biologic therapy expertise.
• Vivo Infusion: Ambulatory infusion center operator offering specialty infusion in a comfortable outpatient setting with strong payor positioning. Direct competitor in the AIC site-of-care channel that Acelpa highlights.
• Option Care Health: Largest U.S. independent provider of home and alternate-site infusion services offering specialty infusion across all 50 states. Direct competitor to Acelpa Health with a similar focus on complex, chronic, and rare condition therapies across home and AIC channels.
• Amerita: Specialty home infusion provider offering complex specialty therapies across multiple therapeutic categories. Comparable in the home infusion channel with similar payor and manufacturer relationship focus.
• Soleo Health: National specialty infusion pharmacy and home infusion provider serving patients with complex conditions. Closely comparable in scale, channel mix (home infusion, AICs), and manufacturer/payor-focused GTM motion.
• BioMatrix SpRx: Specialty pharmacy with deep focus on chronic disease specialty infusion including IG and bleeding disorders. Comparable specialty pharmacy platform with national reach, payor partnerships, and clinical support for complex therapy patients.

Broad incumbents

• BrightSpring Health Services: Public diversified home and community health services platform including specialty pharmacy and home infusion arms (PharMerica/Kabafusion). Operates specialty infusion as one of several service lines, competing for similar patients and payor contracts.
• Accredo (Cigna): Specialty pharmacy and home infusion arm of Cigna's Evernorth/PBM ecosystem. A scaled incumbent that overlaps in services and competes for payor and manufacturer relationships across the specialty infusion space.
• CarelonRx (formerly Avella): Elevance Health-owned specialty pharmacy platform providing specialty infusion and high-touch clinical management. A vertically integrated competitor with structural advantages on payor access through its parent.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/acelpa-health
• Facebookfacebook.com/profile.php

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acelpa Health